Events and Presentations
Immunic’s Inaugural Virtual R&D Day
Agenda
(Eastern time, times are estimates)
09:00 – 09:10 Welcome and Company Introduction
09:10 – 09:30 Introduction to Lead Asset IMU-838
09:30 – 10:00 IMU-838 as a Potential Treatment Option for COVID-19
10:00 – 10:40 KOL Multiple Sclerosis: Robert Fox, MD
10:40 – 11:15 Clinical Development Program for IMU-838
11:15 – 11:25 Introduction to IMU-935
11:25 – 11:40 Positioning of IMU-935 and Ongoing Phase 1 Program
11:40 – 11:50 Introduction to IMU-856
11:50 – 12:30 KOL Inflammatory Bowel Disease: Jean-Frederic Colombel, MD
12:30 – 12:45 Positioning of IMU-856 and Clinical Planning
12:45 – 01:00 Summary and Closing Remarks
